Literature DB >> 10565833

Desensitization of nicotinic agonist-induced [3H]gamma-aminobutyric acid release from mouse brain synaptosomes is produced by subactivating concentrations of agonists.

Y Lu1, M J Marks, A C Collins.   

Abstract

Several neurochemical and electrophysiological studies have shown that neuronal nicotinic receptors are desensitized by pretreatment with lower agonist concentrations than are required to activate the receptors, but the extent of desensitization and agonist concentration required to produce desensitization vary depending upon receptor subtype. Recently, we reported that nicotinic agonists will stimulate the release of [3H]gamma-aminobutyric acid (GABA) from synaptosomes prepared from mouse brain. The studies described herein evaluated desensitization of [3H]GABA release produced by pretreatment with 12 nicotinic agonists. Pretreatment produced near total desensitization that developed slowly (onset T(1/2) = 3.46 min) and was totally reversible (recovery T(1/2) = 4.95 min). Nine of the 12 compounds tested induced total or near total desensitization at concentrations that were less than those required to produce a reliably measured increase in [3H]GABA release. Nicotine produced total block with an IC(50) value of 26 nM. This value is two orders of magnitude lower than the EC(50) for nicotine-induced [3H]GABA release (1630 nM). The three compounds that showed an overlap of the desensitization and activation concentration-effect curves (cytisine, anabasine, nornicotine) are all partial agonists. Comparison of the desensitization properties of the [3H]GABA release with an ion ((86)Rb+) efflux that we have measured previously suggests that the receptor that mediates GABA release and (86)Rb(+) efflux is the same, most likely the alpha4beta2 subtype.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10565833

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  17 in total

Review 1.  Nicotinic modulation of neuronal networks: from receptors to cognition.

Authors:  Huibert D Mansvelder; Karlijn I van Aerde; Jonathan J Couey; Arjen B Brussaard
Journal:  Psychopharmacology (Berl)       Date:  2005-07-02       Impact factor: 4.530

Review 2.  Nicotine reduction revisited: science and future directions.

Authors:  Dorothy K Hatsukami; Kenneth A Perkins; Mark G Lesage; David L Ashley; Jack E Henningfield; Neal L Benowitz; Cathy L Backinger; Mitch Zeller
Journal:  Tob Control       Date:  2010-10       Impact factor: 7.552

Review 3.  Nicotinic receptors containing the alpha7 subunit: a model for rational drug design.

Authors:  G Sharma; S Vijayaraghavan
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

4.  Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells.

Authors:  Salvatore Lecca; Miriam Melis; Antonio Luchicchi; Maria Grazia Ennas; Maria Paola Castelli; Anna Lisa Muntoni; Marco Pistis
Journal:  Neuropsychopharmacology       Date:  2010-11-03       Impact factor: 7.853

5.  Differential effects of non-nicotine tobacco constituent compounds on nicotine self-administration in rats.

Authors:  Brandon J Hall; Corinne Wells; Cheyenne Allenby; Mung Yan Lin; Ian Hao; Lindsey Marshall; Jed E Rose; Edward D Levin
Journal:  Pharmacol Biochem Behav       Date:  2014-02-21       Impact factor: 3.533

6.  Anxiolytic-like and anxiogenic-like effects of nicotine are regulated via diverse action at β2*nicotinic acetylcholine receptors.

Authors:  S M Anderson; D H Brunzell
Journal:  Br J Pharmacol       Date:  2015-03-24       Impact factor: 8.739

7.  Nicotine is highly effective at producing desensitization of rat alpha4beta2 neuronal nicotinic receptors.

Authors:  K G Paradiso; Joe Henry Steinbach
Journal:  J Physiol       Date:  2003-10-10       Impact factor: 5.182

8.  Varenicline and cytisine: two nicotinic acetylcholine receptor ligands reduce ethanol intake in University of Chile bibulous rats.

Authors:  Ramón Sotomayor-Zárate; Katia Gysling; Usoa E Busto; Bruce K Cassels; Lutske Tampier; María Elena Quintanilla
Journal:  Psychopharmacology (Berl)       Date:  2013-01-24       Impact factor: 4.530

9.  Anxiolytic- and antidepressant-like effects of the methadone metabolite 2-ethyl-5-methyl-3,3-diphenyl-1-pyrroline (EMDP).

Authors:  Patrick A Forcelli; Jill R Turner; Bridgin G Lee; Thao T Olson; Teresa Xie; Yingxian Xiao; Julie A Blendy; Kenneth J Kellar
Journal:  Neuropharmacology       Date:  2015-09-11       Impact factor: 5.250

Review 10.  Effects of neuronal nicotinic acetylcholine receptor allosteric modulators in animal behavior studies.

Authors:  Anshul A Pandya; Jerrel L Yakel
Journal:  Biochem Pharmacol       Date:  2013-05-31       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.